Corvus Pharmaceuticals CRVS Cash ratio
Cash ratio at other companies
Other financials
Where this comes from
Calculated from Corvus Pharmaceuticals’s reported figures.
Based on the most recent quarter.
The official record: Corvus Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Corvus Pharmaceuticals's cash ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Corvus Pharmaceuticals's cash ratio?
- Corvus Pharmaceuticals (CRVS) reported cash ratio of 3.3× in Q1 2026.
- How has Corvus Pharmaceuticals's cash ratio changed year-over-year?
- Corvus Pharmaceuticals's cash ratio increased by 514.7% year-over-year, from 0.5× to 3.3×.
- What is the long-term trend for Corvus Pharmaceuticals's cash ratio?
- Over 5 years (2020 to 2025), Corvus Pharmaceuticals's cash ratio has grown at a -18.5% compound annual growth rate (CAGR), from 1.4× to 0.5×.
- What does cash ratio mean?
- Cash and equivalents divided by current liabilities at the quarter end. The most conservative liquidity measure — what the company could pay immediately with cash on hand.